A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

No, side effects from all COVID-19 vaccines are mild and nothing to worry about. But let's look at the specifics and how to cope with them.

Novavax Inc. closed 61.59% short of its 52-week high of $17.81, which the company achieved on July 26th.

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my NVAX stock update.

Supplements are part of the daily routine for over half of adults in the United States. However, they aren't regulated in ...

Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.

Novavax's COVID-19-influenza vaccines show strong immune response in older adults, paving the way for regulatory approval.